BDBM50010176 CHEMBL107009::[(4S,7R,13R,16S)-16-Acetylamino-4-carbamoyl-13-(3-guanidino-propyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid::[16-Acetylamino-4-carbamoyl-13-(3-guanidino-propyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid

SMILES CC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](CCCNC(N)=N)NC1=O)C(N)=O

InChI Key InChIKey=IDMAZMUTHNEQSS-FDYHWXHSSA-N

Data  2 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50010176   

TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010176(CHEMBL107009 | [(4S,7R,13R,16S)-16-Acetylamino-4-c...)
Affinity DataKi:  780nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010176(CHEMBL107009 | [(4S,7R,13R,16S)-16-Acetylamino-4-c...)
Affinity DataKi:  780nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development

Curated by ChEMBL
LigandPNGBDBM50010176(CHEMBL107009 | [(4S,7R,13R,16S)-16-Acetylamino-4-c...)
Affinity DataIC50:  1.62E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed